ECMO News and Research

RSS

Recipients of the Lundbeck Neonatal Nursing Career Path Scholarship announced

Recipients of the Lundbeck Neonatal Nursing Career Path Scholarship announced

The National Association of Neonatal Nurses (NANN) is proud to announce the recipients of the Lundbeck Neonatal Nursing Career Path Scholarship. The program, made possible through a grant from Lundbeck Inc. (formerly Ovation Pharmaceuticals), supports clinical neonatal nurses who seek to advance their education and become neonatal nurse practitioners.

25 Sep 2009

Haemofiltration significantly reduces ECMO duration in newborns

Haemofiltration significantly reduces ECMO duration in newborns

Haemofiltration has already been shown to improve fluid balance in children treated with extracorporeal membrane oxygenation (ECMO) but now researchers writing in BioMed Central's open access journal Critical Care have reported that continuous haemofiltration significantly reduces ECMO duration in newborns.

1 Apr 2009

Racial disparities found in access and use of organ transplantation in children listed for heart transplant

Racial disparities found in access and use of organ transplantation in children listed for heart transplant

Minority children awaiting a donor heart for transplant have a higher death rate than white children, even after controlling for clinical risk factors, according to research presented at the American Heart Association's Scientific Sessions 2008.

11 Nov 2008

Ikaria's INOmax approved in Australia

Ikaria's INOmax approved in Australia

Ikaria Holdings, Inc., through its subsidiary INO Therapeutics LLC, announced today that it has received approval from Australia's regulatory body, the Therapeutic Goods Administration (TGA), for INOmax (nitric oxide) for inhalation.

27 Nov 2007

New generation of implanted heart-assisting pumps help patients survive, regain function til transplant

New generation of implanted heart-assisting pumps help patients survive, regain function til transplant

A new generation of implanted heart-assisting pump does very well at helping severely ill heart-failure patients survive, and thrive, until they receive a heart transplant, a new study shows.

30 Aug 2007

Implantable artificial lung

Implantable artificial lung

The University of Michigan Medical School laboratory working to develop an implantable artificial lung that can serve as a bridge to lung transplantation is entering the home stretch.

6 Aug 2007

Comprehensive care for complex, high-risk pregnancies

Comprehensive care for complex, high-risk pregnancies

As many as 3 percent of all pregnancies result in the birth of a baby with chromosomal anomalies like Down syndrome or structural anomalies such as congenital heart disease.

23 May 2006

Researchers awarded $5 million to develop a pediatric heart assist device

Researchers awarded $5 million to develop a pediatric heart assist device

Penn State researchers recently were awarded a $5 million contract from the National Heart, Lung, and Blood Institute of the National Institutes of Health to develop a pediatric heart assist device.

11 May 2004

$4.5 million contract to develop heart assist devices for infants

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

Previous
1
...
8
9
10
11

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.